i&i Biotech Fund — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
Sophomer is a Czech biotech company developing in vitro diagnostics (IVD) products, working in partnership with academic labs on the design and synthesis of new polymers.
BiotechHealthtechMedical DevicesNew Materials
Martin Burkhard(Founder & Managing Director – CEO, Operations & Development)Jan Plicka(Founder and Inventor & Managing Director – R&D)Jiří Moos(Founder and Inventor & Managing Director, Business Development)inTomáš Etrych(Founder and Inventor & Sophomer's Partner Lab)Libor Kostka(Founder and Inventor & Sophomer's Partner Lab)Vladimír Šubr(Founder and Inventor & Sophomer's Partner Lab)
Co-investorsBiotech Investments S.R.O
Delta Development Team manufactures temperature-controlled medical transport and storage devices, including smart blood coolers and autonomous refrigeration units, for healthcare facilities and blood banks.
HardwareHealthtechLogistics & Supply ChainMedical Devices
Co-investorsAggie Angel NetworkAZ Venture Capital Inc.Central Texas Angel NetworkOost NL
Delta Life Science develops the inQuiQ, a label-free biosensing instrument that uses integrated photonics to measure biomolecular binding affinity and kinetics (KD, ka, kd) in real time from small sample volumes.
BiotechDeep TechHardware
Co-investorsOost NL
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

